Minimum age to purchase tobacco products in US raised to 21
HOUSTON ― The University of Texas MD Anderson Cancer Center applauds the bipartisan legislation approved today raising the legal age to purchase tobacco products, including e-cigarettes, in the U.S. from 18 to 21.
“Raising the national tobacco sale age to 21 is a significant step toward protecting the health of our youth and reducing the leading cause of preventable death in the United States: tobacco use,” said Peter...
Statement regarding the confirmation of Stephen Hahn, M.D., as United States Commissioner of Food and Drugs
The faculty and staff at The University of Texas MD Anderson Cancer Center congratulate Stephen Hahn, M.D., on his confirmation as United...
Combination therapy results in 98% response rate for some newly diagnosed leukemia patients
A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal...
CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy. Findings were presented Dec. 9 at the 61st American Society of Hematology Annual Meeting & Exposition in Orlando, Fla.
The multi-center, Phase II study reported...
Combination therapy more effective than chemotherapy alone for many newly diagnosed leukemia patients
A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine...
MD Anderson-convened consortium provides first universal recommendations for pediatric patients with sinusoidal obstructive syndrome
The University of Texas MD Anderson Cancer Center convened an international panel of multidisciplinary experts earlier this year to evaluate...
MD Anderson clinical trial expert Lee earns election as AAAS Fellow
J. Jack Lee, Ph.D., associate vice president of Quantitative Sciences and Biostatistics at The University of Texas MD Anderson Cancer Center...
Researchers find protein promotes cancer, suppresses anti-tumor immunity
Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can...
A Conversation With a Living Legend to honor Houston Astros’ Jim Crane
The University of Texas MD Anderson Cancer Center will honor business entrepreneur and philanthropist Jim Crane, owner and chairman of the...
San Antonio luncheon to honor former U.S. Sec. of State Rex Tillerson
The University of Texas MD Anderson Cancer Center marks the 10th year of A Conversation With a Living Legend® in San Antonio with a luncheon...
Prostate cancer bone metastases thwart immunotherapy by producing TGF-β
Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint...
Kim Carstens receives Brown Foundation Award for Excellence in Oncology Nursing
Kim Carstens, B.S.N., R.N., O.C.N., is the recipient of the 2019 Brown Foundation Award for Excellence in Oncology Nursing at The University...
MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce the in-licensing by Artios...
Seven volunteers named to MD Anderson Cancer Center Board of Visitors
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV), a nonfiduciary, appointed volunteer advisory board, welcomes seven...
MD Anderson and Varian partner to optimize radiation oncology treatment
The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software...
A Conversation With a Living Legend in Dallas to honor LA Dodgers pitcher Clayton Kershaw
The North Texas A Conversation With a Living Legend® will honor Los Angeles Dodgers starting pitcher Clayton Kershaw in an interview with...
Targeted therapy erdafitinib effective for patients with advanced bladder cancer and specific gene mutations
Treatment with the FGFR inhibitor erdafitinib in patients with metastatic bladder cancers marked by mutations in the FGFR3 gene resulted in...
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment...
Rogers Award honors Sheryl Harris, C.N.A., for excellence in patient care
The University of Texas MD Anderson Cancer Center has awarded Sheryl Harris, C.N.A., the Julie and Ben Rogers Award for Excellence in Patient...
MD Anderson and Houston Dynamo unite to kick childhood cancer
The University of Texas MD Anderson Cancer Center goes gold for Kick Childhood Cancer Awareness Night at BBVA Stadium, Saturday, Sept. 21...
In Memory of T. Boone Pickens
The University of Texas MD Anderson Cancer Center extends deepest sympathy to family and friends of philanthropist and energy...
MD Anderson study confirms protein as potential cause of most common type of pancreatic cancer
Researchers at The University of Texas MD Anderson Cancer Center have confirmed a protein as an oncogene responsible for the most common and...
MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
The University of Texas MD Anderson Cancer Center received a notice of renewal from the National Cancer Institute (NCI) to extend its status...
MD Anderson receives more than $19 million in CPRIT funding
The University of Texas MD Anderson Cancer Center today was awarded more than $19 million from the Cancer Prevention and Research Institute...
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a new multi-year partnership to conduct collaborative...
Bacteria on tumors influences immune response and survival of patients with pancreatic cancer
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes...
MD Anderson to expand Proton Therapy Center
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a groundbreaking ceremony. The...
Discovery shows how difficult-to-treat prostate cancer evades immune system
Researchers at The University of Texas MD Anderson Cancer Center have discovered how an aggressive form of prostate cancer called double-negative...
New biomarker-guided strategy has potential for liver cancer treatment
A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing...
Joel Dahmen named MD Anderson's official PGA TOUR ambassador
The University of Texas MD Anderson Cancer Center, the official cancer center of the PGA TOUR, today announced its partnership with Joel Dahmen...